tiprankstipranks
Trending News
More News >
Merck & Company (DE:6MK)
XETRA:6MK

Compare Merck & Company (6MK) vs. Competitors

Compare
68 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Merck & Company
€89.10
€224.88B
13.06
-6.11%
9 Buy
5 Hold
0 Sell
Moderate Buy
AstraZeneca
$92.90
$286.35B
30.61
44.64%
6 Buy
0 Hold
0 Sell
Strong Buy
Gilead Sciences
$124.70
$154.71B
19.31
39.31%
15 Buy
4 Hold
0 Sell
Strong Buy
Novartis
$139.18
$265.67B
18.85
47.34%
1 Buy
2 Hold
1 Sell
Hold
Pfizer
$25.09
$142.65B
14.62
1.83%
5 Buy
10 Hold
0 Sell
Moderate Buy
Sanofi
$48.47
$116.50B
12.05
3.70%
2 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:6MK
Merck & Company
89.10
-2.86
-3.11%
AZN
AstraZeneca
92.90
28.67
44.64%
GILD
Gilead Sciences
124.70
35.19
39.31%
NVS
Novartis
139.18
44.72
47.34%
PFE
Pfizer
25.09
0.45
1.83%
SNY
Sanofi
48.47
1.73
3.70%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts